A role for p38 MAP kinase in platelet activation by von Willebrand factor

Thrombosis and Haemostasis

Volumn 91, Issue 1, 2004, Pages 102-110

  Canobbio, Ilaria ^a   Reineri, Stefania ^b   Sinigaglia, Fabiola ^b   Balduini, Cesare ^a   Torti, Mauro ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Arachidonic acid; p38 MAP kinase; Phospholipase A2; Tyrosine phosphorylation; Von Willebrand factor

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ARACHIDONIC ACID; FC GAMMA RECEPTOR IIA; FC RECEPTOR; GLYCOPROTEIN; GLYCOPROTEIN IB IX V; INTEGRIN; INTEGRIN ALPHAIIBBETA3; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCLONAL ANTIBODY; PHOSPHOLIPASE A2; PHOSPHOTRANSFERASE; PICEATANNOL; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE INHIBITOR; THROMBOXANE A2; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ARTICLE; CYTOSOL; DRUG EFFECT; DRUG INHIBITION; DRUG SYNTHESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

EID: 1642556698     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th03-02-0083     Document Type: Article

References (40)

1. Widmann C, Gibson S, Jarpe MB, et al. Mitogen-activated protein kinase: Conservation of three-kinase module from yeast to human. Physiol Rev 1999; 79: 143-80.
2. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002; 298: 1911-12.
3. Wilkinson MG, Millar JBA. Control of the eukaryotic cell cycle by MAP kinase signalling pathways. FASEB J 2000; 14: 2147-57.
4. Marshall CJ. Specificity of receptor tyrosine kinase signalling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 1995; 80: 179-85.
5. Marshall CJ. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr Opin Genet Dev 1994; 4: 82-89.
6. Ip YT, Davis RJ. Signal transduction by the c-jun N-terminal kinase (JNK) - From inflammation to development. Curr Opin Cell Biol 1998; 10: 205-19.
7. Tournier C, Hess P, Yang DD, et al. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 2000; 288: 870-4.
8. New L, Han J. The p38 MAP kinase pathway and its biological function. Trend Card Med 1998; 8: 220-28.
9. Ono K, Han J. The p38 signal transduction pathway. Activation and function. Cell Signal 2000; 12: 1-13.
10. Papkoff J, Chen RH, Blenis J, et al. p42 mitogen-activated protein kinase and p90 ribosomal S6 kinase are selectively phosphorylated and activated during thrombin-induced platelet activation and aggregation. Mol Cell Biol 1994; 14: 463-72.
11. Kramer RM, Roberts EF, Strifler BA, et al. Thrombin induces activation of p38 MAP kinase in human platelets. J Biol Chem 1995; 270: 27395-8.
12. Bugaud F, Nadal-Woolbold F, Levy-Toledano S, et al. Regulation of c-jun-NH2 terminal kinase and extracellular-signal regulated kinase in human platelets. Blood 1999; 94: 3800-5.
13. Nakashima S, Chatani Y, Nakamura M, et al. Tyrosine phosphorylation and activation of mitogen-activated protein kinases by thrombin in human platelets: Possible involvement in late arachidonic acid release. Biochem Biophys Res Commun 1994; 198: 497-503.
14. Aharonovitz O, Granot Y. Stimulation of mitogen-activated protein kinase and Na+/H+ exchanger in human platelets. Differential effect of phorbol ester and vasopressin. J Biol Chem 1996; 271: 16494-9.
15. Borsch-Haubold AG, Kramer RM, Watson SP. Cytosolic phospholipase A2 is phosphorylated in collagen- and thrombin-stimulated human platelets independent of protein kinase C and mitogen-activated protein kinase. J Biol Chem 1995; 270: 25885-92.
16. 2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets. Eur J Biochem 1997; 245: 751-9.
17. 3. J Biol Chem 2001; 276: 42226-32.
18. 3 in platelets. J Biol Chem 1997; 272: 22381-4.
19. Saklatvala J, Rawlinson L, Waller RJ, et al. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue. J Biol Chem 1996; 271: 6586-9.
20. Hackeng CM, Relou IA, Pladet MW, et al. Early platelet activation by low density lipoprotein via p38MAP kinase. Thromb Haemost 1999; 82: 1749-56.
21. Borsch-Haubold AG, Kramer RM, Watson SP. Inhibition of mitogen-activated protein kinase kinase does not impair primary activation of human platelets. Biochem J 1996; 318: 207-12.
22. 2. J Biol Chem 1996; 271: 27723-9.
23. 2 in agonist-stimulated human platelets and HeLa cells. J Biol Chem 1998; 273: 4449-58.
24. 2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell 1991; 65: 1043-51.
25. 2 with membrane in the macrophage cell line RAW 264.7. J Biol Chem 1990; 265: 5409-13.
26. Kroll MH, Harris TS, Moake JL, et al. von Willebrand factor binding to platelet GPIb initiates signals for platelet activation. J Clin Invest 1991; 88: 1568-73
27. Torti M, Bertoni A, Canobbio I, et al. Rap1B and Rap2B translocation to the cytoskeleton by von Willebrand factor involves FcγIIA receptor-mediated protein tyrosine phosphorylation. J Biol Chem 1999; 274: 13690-7.
28. Ozaki Y, Satoh K, Yatomi Y, et al. Protein tyrosine phosphorylation in human platelets induced by interaction between glycoprotein Ib and von Willebrand factor. Biochim Biophys Acta 1995; 1243: 482-8.
29. Asazuma N, Ozaki Y, Satoh K, et al. Glycoprotein Ib-von Willebrand factor interactions activate tyrosine kinases in human platelets. Blood 1997; 90: 4789-98.
30. Sullam PM, Hyun WC, Szollosi J, et al. Physical proximity and functional interplay of the glycoprotein Ib-IX-V complex and the Fc receptor FcγRIIA on the platelet plasma membrane. J Biol Chem 1998; 273: 5331-6.
31. Sun B, Li J, Kambayashi J. Interaction between GPIbα and FcγIIA receptor in human platelets. Biochem Biophys Res Commun 1999; 266: 24-7.
32. Shrimpton CN, Borthakur G, Larrucea S, et al. Localization of the adhesion receptor glycoprotein Ib-IX-V complex to lipid rafts is required for platelet adhesion and activation. J Exp Med 2002; 196: 1057-66.
33. 2 and FcγIIA receptor. J Biol Chem 2001; 276: 26022-9.
34. Torti M, Ramaschi G, Sinigaglia F, et al. Association of the low molecular weight GTP-binding protein rap2B with the cytoskeleton during platelet aggregation. Proc Natl Acad Sci U S A. 1993; 90: 7553-7.
35. Canobbio I, Lova P, Sinigaglia F, et al. Proline-rich tyrosine kinase 2 and focal adhesion kinase are involved in different phases of platelet activation by VWF. Thromb Haemost 2002; 87: 509-17.
36. 3 signaling in platelets. Blood 1999; 93: 2645-52.
37. Wu Y, Suzuki-Inoue K, Satoh K, et al. Role of Fc receptor γ-chain in platelet glycoprotein Ib-mediated signaling. Blood 2000; 97:3836-45.
38. 2 activity by either FcγRIIA or FcγRIIIB in human neutrophils. A possible role for Pyk2 but not for the Grb2-Sos-Shc complex. J Biol Chem 2000; 275: 12416-23.
39. Pandey P, Avraham S, Kumar S, et al. Activation of p38 mitogen-activated protein kinase by PYK2/related adhesion focal tyrosine kinase-dependent mechanism. J Biol Chem 1999; 274: 10140-4.
40. Borsch-Haubold AG, Pasquet S, Watson SP. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059. SB 203580 also inhibits thromboxane synthase. J Biol Chem 1998; 273: 28766-72.